Manipulation of the anti-αGal antibody-αGal epitope system in experimental discordant xenotransplantation

Xenotransplantation

Volumn 3, Issue 1 PART 2, 1996, Pages 102-111

  Cooper, D K C ^a   Koren, E ^b   Oriol, R ^b  

^a INTEGRIS Nazih Zuhdi Transplant Institute   (United States)

^b NONE

Author keywords

Anti Gal antibodies; Xenotransplantation; Gal epitopes

Indexed keywords

EID: 0002746429     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.1996.tb00126.x     Document Type: Article

References (62)

1. COOPER DKC, YE Y, ROLF LL JR, ZUHDI N. The pig as potential organ donor for man. Cooper, DKC et al., eds. In: Xenotransplantation. Heidelberg: Springer, 1991, p. 481.
2. PLATT JL, BACH FH. Mechanism of tissue injury in hyperacute xenograft rejection. In: Xenotransplantation. Cooper, DKC et al. eds. Heidelberg: Springer, 1991, p. 69.
3. ROSE AG, COOPER DKC, HUMAN PA, REICHENSPURNER H, REICHART B. Histopathology of hyperacute rejection of the heart - experimental and clinical observations in allografts and xenografts. J Heart Lung Transplant 1991:10:223.
4. KOBAYASHI T, TANIGUCHI S, YE Y, et al. Prolongation of graft survival following pig-to-baboon heart transplantation by cobra venom factor (CVF) without natural antibody depletion. Presented to the International Society for Heart and Lung Transplantation, San Francisco, 1995. Submitted for publication.
5. GOOD H, COOPER DKC, MALCOLM AJ, et al. Identification of carbohydrate structures which bind human anti-porcine antibodies: implications for discordant xenografting in man. Transplant Proc 1992:24:559.
6. COOPER, DKC. Depletion of natural antibodies in non-human primates - a step towards successful discordant xenografting in humans. Clin Transplantation 1992:6:178.
7. COOPER, DKC. Is Xenotransplantation a realistic clinical option? Transplant Proc 1992:24:2393.
8. COOPER DKC, GOOD AH, MALCOLM AJ, et al. Specific intravenous carbohydrate therapy - a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting. Transplant Proc 1993:25:377.
9. COOPER DKC, GOOD AH, KOREN E, et al. Identification of α-galactosyl and other carbohydrates that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol 1993:1:198.
10. KOREN E, NEETHLING FA, YE Y, et al. Heterogeneity of preformed human antipig xenogeneic antibodies. Transplant Proc 1992:24:598.
11. KOREN E, NEETHLING FA, RICHARDS S, et al. Binding and specificity of major immunoglobulin classes of preformed human anti-pig heart antibodies. Transpl Int 1993:6:351.
12. KUJUNDZIC M, KOREN E, NEETHLING FA, et al. Variability of anti-αGal antibodies in human serum and their relation to serum cytotoxicity against pig cells. Xenotransplantation 1994:1:58.
13. RIEBEN R, VON ALLMEN E, KORCHAGINA EY, et al. Detection, immunoadsorption, and inhibition of cytotoxic activity of anti-αGal antibodies using newly developed substances with synthetic Galα1-3Ga1 disaccharide epitopes. Xenotransplantation 1995:2:98.
14. GALILI U, RACHMILEWITZ EA, PELEG A, FLECHNER I. A unique natural human IgG antibody with anti-galactosyl specificity. J Exp Med 1984:260:1519.
15. CAIRNS T, LEE J, GOLDBERG L, et al. Polymorphism within the human IgG anti-pig repertoire. (Abstract) Presented to the British Transplantation Society, Manchester, U.K., 1995.
16. KOREN E, MILOTEC F, NEETHLING FA, et al. Mouse monoclonal anti-idiotypic antibodies directed against human anti-αGal antibodies reduce cytotoxicity of human and baboon sera to pig cells in culture. Transplantation, in press.
17. MAKOWKA L, CRAMER DV, HOFFMAN A, et al. The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure. Transplantation 1995:59:1654.
18. KOBAYASHI T, NEETHLING FA, KOREN E, et al. In vitro and in vivo investigation of the potential roles of the anti-complement agents, FUT-175 and K76COOH, in the prevention of hyperacute rejection following discordant xenotransplantation. Transplant Proc, in press.
19. BACKER AE, Holgersson J, KARLSSON H, et al. Structural characterization of glycosphingolipids in different organs of a semi-inbred pig strain using GC/MS of ceramide glycanase-released oligosaccharides. Presented to the Second International Congress on Xenotransplantation, Cambridge, U.K., 1993.
20. KARLSSON E, CAIRNS T, HOLGERSSON J, et al. Pig-to-human xenotransplantation. Confirmation of a major target epitope of preformed human natural IgG and IgM anti-pig-terminal galactose α1,3galactose. Glycoconjucate J 1993:10:297.
21. SAMUELSSON BE, RYDBERG L, BREIMER ME, et al. Natural antibodies and human xenotransplantation. Immunol Rev 1994:141:151.
22. VAUGHAN HA, DABKOWSKI PL, MCKENZIE IFC, SANDRIN M. Biochemical analysis of pig xenoantigens detected by human antibodies. Transplant Proc 1993:25:2919.
23. ORIOL R, YE Y, KOREN E, COOPER DKC. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993:56:1433.
24. ORIOL R, BARTHOD F, BERGEMER A-M, et al. Monomorphic and polymorphic carbohydrate antigens on pig tissues: implications for organ xenotransplantation in the pig-to-man model. Transplant Int 1994:7:405.
25. ALVARADO CG, COTTERELL AH, MCCURRY KR, et al. Variation in the level of xenoantigen expression in porcine organs. Transplantation 1995:59:1589.
26. ORIOL R, CANDELIER JJ, TANIGUCHI S, et al. Major oligosaccharide epitopes found in tissues of 20 animal species: implications for experimental and clinical organ xenotransplantation. Transplant Proc, in press.
27. TANIGUCHI S, NEETHLING FA, KOBAYASHI T, et al. The ratites (ostrich, emu) as potential heart donors for humans - immunologic considerations. Transplant Proc, in press.
28. ROSE AG, KOBAYASHI T, KOSANKE S, WHITE DJG, COOPER DKC. Histopathology of delayed vascular (humoral) rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor. Prominent role of venular thrombosis. Submitted for publication.
29. ROSE AG, COOPER DKC. A histopathologic grading system of hyperacute and delayed vascular (humoral, antibody-mediated) cardiac xenograft and allograft rejection. J Heart Lung Transplant. In press.
30. KEMP E. Experimental xenotransplantation between distantly-related non-primate species. In: Xenotransplantation Cooper, DKC, et al. eds., Heidelberg: Springer, 1991, p. 377.
31. HUNT BJ, ROSENBERG RD. The essential role of hemostasis in hyperacute rejection. Xeno 1993:1:16.
32. HUNT BJ, DUNNING JJ, SEGAL H, et al. Pig-to-human xenograft reaction: is hemostatic activation dependent on the presence of anti-pig antibodies or complement? Transplant Proc 1994:26:156.
33. JURD KM, CAIRNS T, HUNT BJ. Activation of hemostasis in an in vitro model of the pig-to-human xenograft reaction. Transplant Proc 1994:26:1159.
34. HOFER E, STUHLMEIER KM, BLAKELY ML, et al. Pathways of procoagulation n discordant xenografting. Transplant Proc 1994:26:1322.
35. BACH FH, ROBBERSON FC, FERRAN C, et al. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev 1994:141:5.
36. BACH FH, ROBSON SC, WINKLER H, et al. Barriers to Xenotransplantation. Nature Med 1995:1:869.
37. SACHS DH, SYKES M, GREENSTEIN JL, COSIMI AB. Tolerance and xenograft survival. Nature Med 1995:1:969.
38. ORIOL R, COOPER JE, DAVIES DR, KEELING PWN. ABH antigens in vascular endothelium and some epithelial tissues of baboons. Lab Invest 1984:50:414.
39. GALILI U, SHOHET SB, KOBRIN E, et al. Man, apes and Old World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J Biol Chem 1988:263:17755
40. KOREN E, NEETHLING FA, KOSCEC M, et al. In vitro model for hyperacute rejection of xenogeneic cells. Transplant Proc 1994:26:1166
41. NEETHLING FA, KOREN E, YE Y, et al. Protection of pig kidney (PK15) cells from the cytotoxic effect of anti-pig antibodies by α-galactosyl oligosaccharides. Transplantation 1994:57:959.
42. NEETHLING F, JOZIASSE D, BOVIN N, et al. The reducing end of αGal oligosaccharides contributes to their efficiency in blocking natural antibodies of human and baboon sera. Transplant Int 1996:9:98.
43. YE Y, NEETHLING FA, NIEKRASZ M, et al. Evidence that intravenously administered α-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney (PK15) cells and transplanted pig hearts. Transplantation 1994:58:330.
44. ZHAO Z, MICHALSKI JC, CHEREAU C, et al. An approach to the structure of carbohydrate epitopes recognized by human natural antibodies on porcine endothelial cells. Presented to the Second International Congress on Xenotransplantation, Cambridge, UK, 1993.
45. LI S, YEH J-C, COOPER DKC, CUMMINGS RD. Inhibition of human anti-αGal IgG by oligosaccharides derived from porcine stomach mucin. Xenotransplantation, 1995:2:279.
46. GOWDA DC, PETRELLA EC, RAJ TT, BREDEHORST R, VOGEL CW. Immunoreactivity and function of oligosaccharides in cobra venom factor. J Immunol 1994:152:2977.
47. SCHAAPHERDER AFM, GOOSZEN HG, TE BULTE M-TJW, DAHA MR. Human complement activation via the alternative pathway on porcine endothelium initiated by IgA antibodies. Transplantation 1995:60:287.
48. COOPER DKC, KOREN E, ORIOL R. Genetically engineered pigs. Lancet 1993:342:682
49. GALILI U. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993:14:480.
50. SANDRIN MS, VAUGHAN HA, DABKOWSKI PL, MCKENZIE IFC. Anti-pig IgM antibodies in human serum react predominantly with Gal(α1-3)GaI epitopes. Proc Natl Acad Sci USA 1993:90:11391.
51. SPIRO RG, BHOYROO VD. Occurrence of α-D-galactosyl residues in the thyroglobulins from several species. J Biol Chem 1994:259:9858.
52. LARSEN RD, RAJAN VP, RUFF M, et al. Isolation of a cDNA encoding murine UDP galactose: β-D-galactosyl-1,4-N-acetyl-D-glucosaminide α-1,3-galactosyltransferase: Expression cloning by gene transfer. Proc Natl Acad Sci USA 1989:86:8227.
53. 4. J Cell Biochem 1989:13A:129.
54. JOZIASSE DH, SHAPER JH, VAN DEN EIJNDEN DH, et al. Bovine α1-3 galactosyltransferase: isolation and characterization of a cDNA clone Identification of homologous sequences in human genomic DNA. J Biol Chem 1989:264:14290.
55. DABKOWSKI PL, VAUGHAN HA, MCKENZIE IFC, SANDRIN MS. Characterization of a cDNA clone encoding the pig α1,3galactosyltransferase: implications for xenotransplantation Transplant Proc 1993:25:2921.
56. COOPER DKC, KOREN E, ORIOL R. Oligosaccharides and discordant xenotransplantation. Immunol Rev 1994:141:31.
57. SANDRIN MS, MOUHTOURIS E, OSMAN N, et al. Elimination of the major porcine xenoantigen, Galα(1,3)Gal, by expression of α(1,2)fucosyltransferase Presented at Glyco XIII, Seattle, USA, 1995.
58. BISHOP DF, CALHOUN DH, BERNSTEIN HS, et al. Human α-galactosidase A: nucleotide sequence of a cDNA clone encoding the mature enzyme. Proc Natl Acad Sci USA 1986:83:4859.
59. DEN HERDER IF, MATEO ROSELL AM, VAN ZUILEN CM, PUNT PJ, VEN DEN HONDEL CAMJJ Cloning and expression of a member of the Aspergillus niger gene family encoding ccgalactosidase. Mol Gen Genet 1992:233:404.
60. ZHU A, GOLDSTEIN J. Cloning and functional expression of a cDNA encoding coffee bean α-galactosidase. Gene 1994:140:227.
61. LIM CS, CHAPMAN GD, GAMMON RS, et al. Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. Circulation 1991:83:2007.
62. ARDEHALI A, FYFE A, LAKS H, et al. Direct gene transfer into donor hearts at the time of harvest. J Thorac Cardiovasc Surg 1995:109:716.